无码人妻一区二区三区三,精品国自产在线,波多野结衣 无码 国产,欧美大片一区

        歡迎選擇我們,上海恒遠生物科技有限公司!免費服務熱線:400-0899-208          防偽查詢

        語言:Eng

        您當前的位置:
        首頁>
        產品中心>
        抗體>
        重組抗體>
        SARS-CoV-2 Spike RBD...

        重組抗體

        SARS-CoV-2 Spike RBD Nanobody

          恒遠生物抗體平臺現已擁有4萬多種抗體(含單抗和多抗),包括人類常用抗體,模式生物類相關抗體、小分子抗體、二抗、標簽抗體及內參抗體等。并以每年4000種的速度在持續增長。

          恒遠生物擁有專業的質控團隊,配備先進實驗儀器,現已成功地建立了ChIP平臺,因此我們的抗體不僅能提供Biotin、FITC、HRP等標記,大部分抗體都能進行ELISA、WB、IHC、IF、IP、ChIP等應用驗證。

          我們致力于為所有用戶提供高親和力、高特異性的優質抗體,歡迎來電咨詢。

        SARS-CoV-2 Spike RBD Nanobody

         
        • 貨號:
          HYK-200093
        • 規格:
           
        • 圖片:
          • The Binding Activity of SARS-CoV-2 Spike RBD Nanobody with SARS-CoV-2-S1-RBD
            Activity: Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2-S1-RBD () at 2 μg/ml can bind SARS-CoV-2 Spike RBD Nanobody, the EC50 is 0.8674 ng/ml.
          • In the Colloidal Gold Immunochromatography Assay
            detection system, the background of antibody (CSB-RA33245A2GMY) is clean, the detection limit can be as low as 25ng/ml (1.75ng/0.07ml), and the sensitivity is very good.
          • Binding signal of SARS-CoV-2-S1-RBD () and ACE2 protein-HRP conjugate () was inhibited by SARS-CoV-2 Spike RBD Nanobody (CSB-RA33245A2GMY) with the ICC50 is 1.296 nM.
          • Binding signal of SARS-CoV-2-S1-RBD () and ACE2 protein-HRP conjugate () was inhibited by SARS-CoV-2 Spike RBD Nanobody (CSB-RA33245A2GMY) with the IC50 is 0.1074 μg/ml.
          • SARS-CoV-2 Spike protein RBD His/Sumostar Tag () captured on COOH chip can bind SARS-CoV-2 Spike RBD Nanobody (CSB-RA33245A2GMY) with an affinity constant of 28.2nM as detected by LSPR Assay.

        產品詳情

        • 產品描述:

          This SARS-CoV-2 S1-RBD (Spike Glycoprotein S1 receptor-binding domain) antibody is a recombinant monoclonal antibody (also a Nanobody) generated through the expression of a DNA sequence inserting a human IgG1 Fc domain at the C-terminus, in human embryonic kidney 293 cells (HEK293). The DNA sequence encodes the SARS-CoV-2 spike RBD. The antibody is purified by protein G in vitro. It has been validated with high reactivity towards SARS-CoV-2 S1-RBD by a functional ELISA and good sensitivity for human SARS-CoV-2 spike glycoprotein (S protein) via the Colloidal Gold Immunochromatography Assay (GICA).
          It is also validated in Neutralizing and LSPR. In neu assay, the binding signal of the SARS-CoV-2 S1 RBD antibody was inhibited by ACE2 protein-HRP conjugated inhibitor, with a 0.1074 μg/ml IC50. In LSPR assay, the SARS-CoV-2 S1 RBD antibody showed a high affinity with SARS-CoV-2 Spike protein RBD (affinity constant: 28.2nM).
          Specifically binding and recognizing the RBD of the SARS-CoV-2 spike glycoprotein, the SARS-CoV-2 S1 RBD antibody can react with samples infected with human coronavirus SARS-CoV-2. But it does not respond to MERS or SARS-CoV spike protein. Akin to other nanobodies, this recombinant nanobody is small and stable, which allows for its reaching to hidden epitopes such as crevices of target proteins.

        • Uniprot No.:
          P0DTC2
        • 別名:
          Anti-coronavirus spike Antibody; Anti-cov spike Antibody; Anti-ncov RBD Antibody; Anti-ncov S1 Antibody;Anti-ncov spike Antibody; Anti-novel coronavirus RBD Antibody; Anti-novel coronavirus S1 Antibody; Anti-novel coronavirus spike Antibody; Anti-RBD Antibody; Anti-S1 Antibody; Anti-Spike RBD Antibody; E2 Antibody; E2 glycoprotein Antibody; Human coronavirus spike glycoprotein Antibody; S Antibody; SARS-CoV-2 S1 RBD Antibody; S glycoprotein Antibody; Spike glycoprotein Antibody
        • 反應種屬:
          Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)
        • 免疫原:
          Recombinant Human Novel Coronavirus Spike glycoprotein(S) (319-541aa) (CSB-YP3324GMY1 and CSB-MP3324GMY1b1)
        • 免疫原種屬:
          Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)
        • 標記方式:
          Non-conjugated
        • 克隆類型:
          Monoclonal
        • 抗體亞型:
          VHH fusion with human IgG1 Fc
        • 純化方式:
          Affinity-chromatography
        • 克隆號:
          A1
        • 濃度:
          It differs from different batches. Please contact us to confirm it.
        • 保存緩沖液:
          Preservative: 0.03% Proclin 300
          Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
        • 產品提供形式:
          Liquid
        • 應用范圍:
          ELISA, GICA, Neutralising
        • 推薦稀釋比:
          Application Recommended Dilution
          ELISA 1:10000-1:100000
          GICA 1:10000-1:40000
          Neutralising 1:100-1:10000
        • Protocols:
          ELISA Protocol
        • 儲存條件:
          Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
        • 貨期:
          Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.


        N Antibody

        SARS-CoV-2 Spike RBD Nanobody, HRP conjugated

        SARS-CoV-2 Spike RBD Nanobody, FITC conjugated

        SARS-CoV-2 Spike RBD Nanobody, Biotin conjugated

        Phospho-Histone H3.3 (T3) Antibody

        Di-methyl-Histone H3.1(K4)Antibody


        在線詢價

        • *
        • *
        • *
        • *
        • *
        • *

        相關產品

        Histone H3.1 Antibody

        Histone H3.1 Antibody

        恒遠生物抗體平臺現已擁有4萬多種抗體(含單抗和多抗),包括人類常用抗體,模式生物類相關抗體、小分子抗體、二抗、標簽抗體及內參抗體等。并以每年4000種的速度在持續增長。

        查看詳細
        CD9 Antibody

        CD9 Antibody

        恒遠生物抗體平臺現已擁有4萬多種抗體(含單抗和多抗),包括人類常用抗體,模式生物類相關抗體、小分子抗體、二抗、標簽抗體及內參抗體等。并以每年4000種的速度在持續增長。

        查看詳細
        Acetyl-Histone H3.1(K56)Antibody

        Acetyl-Histone H3.1(K56)Antibody

        恒遠生物抗體平臺現已擁有4萬多種抗體(含單抗和多抗),包括人類常用抗體,模式生物類相關抗體、小分子抗體、二抗、標簽抗體及內參抗體等。并以每年4000種的速度在持續增長。

        查看詳細

        請輸入搜索關鍵字

        確定